3D rendering of a coronavirus

Preventing COVID-19 spread during patient transport

This page provides recommendations for emergency medical services (EMS) agencies providing transport for the high-risk COVID-19 patient population.

This guidance applies to all EMS delivery models including but not limited to: free standing, municipal third-service; fire-based; hospital-based; private; independent; volunteer and related EMS providers.

Purpose

This guidance provides recommendations for EMS agencies to protect their personnel from COVID-19 exposure while providing transport of patients in the high-risk period of disease transmission.

Definitions

Based upon available information to date, those at high risk for severe illness from COVID-19 include:

Preventative actions for transporting personnel and patients at high-risk for severe COVID-19 illness

  1. Assess the patient for fever, difficulty breathing, dry cough, GI problems, and respiratory symptoms.
  2. Ask the patient if they have had contact with someone diagnosed with or being checked for COVID-19. Updated PPE recommendations for the care of patients with known or suspected COVID-19:
  3. Place surgical facemask on any patient that is contacted/transported.
  4. Wear recommended PPE when transporting patients with possible COVID-19.
  5. Family members and other contacts of patients with possible COVID-19 should not ride in the transport vehicle. Consideration may be given for a family member or guardian to go with the patient if the patient is a minor or there is a specific reason the family member or guardian needs to be with the patient in the transport vehicle. Individuals accompanying the patient should wear a facemask.
  6. On arrival to the facility/home, EMS/transport personnel should remove and discard PPE and perform hand hygiene. Used PPE should be discarded in accordance with established procedures.
  7. All persons in the transport vehicle should avoid touching their face, mouth, nose and eyes.
  8. Perform hand hygiene often, as well as before and after each patient contact.
  9. When transporting a patient to an appointment (e.g., to dialysis or medical office), ensure patients have contact information for their primary care provider/specialist, and that they have called ahead of their appointment to report fever or respiratory symptoms so the facility can be prepared for their arrival or triage them to an appropriate setting.
  10. Inform staff of any patient fever or respiratory symptoms immediately prior to arrival to the facility.
  11. Use cleaning procedures appropriate for SARS-CoV-2 (the virus that causes COVID-19), along with all routine cleaning and disinfection procedures. Refer to List N on the EPA website for EPA-registered disinfectants that have qualified under EPA’s emerging viral pathogens program for use against SARS-CoV-2.
  12. After transporting the patient and decontaminating the unit, leave the rear doors of the transport vehicle open to allow for enough air exchange to remove potentially infectious particles.
  13. The time it takes to complete transfer of the patient to the receiving facility and completion of all documentation should provide air changes for sufficient decontamination.
  14. When possible, use vehicles that have isolated driver and patient compartments that can provide separate ventilation to each area.
  15. If a vehicle does not have an isolated driver compartment then ventilation should be used, open the outside air vents in the driver area and turn on the rear exhaust ventilation fans to the highest setting. This may create a negative pressure gradient in the patient area.

Contingency planning

Follow EMS System medical director guidelines which may change based on evolving COVID-19 guidance.

Understand that many patients need to continue their medical and procedure appointments in order to maintain their health, (e.g., dialysis treatment). Postponing or canceling their visits may be detrimental to their health.

Additional resources

See these resources from the Centers for Disease Control and Prevention:

Download this guidance

This guidance was developed by the Federal Healthcare Resilience Task Force (HRTF). The HRTF is leading the development of a comprehensive strategy for the U.S. healthcare system to facilitate resiliency and responsiveness to the threats posed by COVID-19. The Task Force's EMS/Pre-Hospital Team is comprised of public and private-sector EMS and 911 experts from a wide variety of agencies and focuses on responding to the needs of the pre-hospital community. This team is composed of subject matter experts from NHTSA OEMS, CDC, FEMA, USFA, U.S. Army, USCG and non-federal partners representing stakeholder groups and areas of expertise. Through collaboration with experts in related fields, the team develops practical resources for field providers, supervisors, administrators, medical directors and associations to better respond to the COVID-19 pandemic.

Primary Point of Contact: NHTSA Office of EMS, nhtsa.ems@dot.gov, 202-366-5440